company background image
1066 logo

Shandong Weigao Group Medical Polymer SEHK:1066 Lagerbericht

Letzter Preis

HK$4.54

Marktkapitalisierung

HK$20.8b

7D

-7.9%

1Y

-42.2%

Aktualisiert

18 Nov, 2024

Daten

Finanzdaten des Unternehmens +

Shandong Weigao Group Medical Polymer Company Limited

SEHK:1066 Lagerbericht

Marktkapitalisierung: HK$20.8b

1066 Aktienübersicht

Die Shandong Weigao Group Medical Polymer Company Limited ist in der Volksrepublik China in den Bereichen Forschung und Entwicklung, Produktion, Großhandel und Verkauf von medizinischen Geräten tätig. Mehr Details

1066 grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung6/6
Künftiges Wachstum1/6
Vergangene Leistung2/6
Finanzielle Gesundheit6/6
Dividenden4/6

Belohnungen

59.2% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 10.28% pro Jahr

Im Vergleich zu Wettbewerbern und der Branche gut bewertet

Analysten sind sich einig, dass der Aktienkurs um 46.4%

Risikoanalyse

Unbeständige Dividendenentwicklung


Shandong Weigao Group Medical Polymer Company Limited Wettbewerber

Shanghai Conant Optical

SEHK:2276

HK$6.3b

Kangji Medical Holdings

SEHK:9997

HK$7.2b

OrbusNeich Medical Group Holdings

SEHK:6929

HK$3.5b

Shanghai INT Medical Instruments

SEHK:1501

HK$5.2b

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Shandong Weigao Group Medical Polymer
Historische Aktienkurse
Aktueller AktienkursHK$4.54
52-Wochen-HochHK$8.02
52-Wochen-TiefHK$3.60
Beta0.45
11 Monat Veränderung-7.72%
3 Monate Veränderung15.82%
1 Jahr Veränderung-42.17%
33 Jahre Veränderung-60.38%
5 Jahre Veränderung-52.21%
Veränderung seit IPO2,531.88%

Aktuelle Nachrichten und Updates

Be Wary Of Shandong Weigao Group Medical Polymer (HKG:1066) And Its Returns On Capital

Nov 04
Be Wary Of Shandong Weigao Group Medical Polymer (HKG:1066) And Its Returns On Capital

Analysts Have Been Trimming Their Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Price Target After Its Latest Report

Sep 24
Analysts Have Been Trimming Their Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Price Target After Its Latest Report

Recent updates

Be Wary Of Shandong Weigao Group Medical Polymer (HKG:1066) And Its Returns On Capital

Nov 04
Be Wary Of Shandong Weigao Group Medical Polymer (HKG:1066) And Its Returns On Capital

Analysts Have Been Trimming Their Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Price Target After Its Latest Report

Sep 24
Analysts Have Been Trimming Their Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Price Target After Its Latest Report

Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Just Reported, And Analysts Assigned A HK$6.74 Price Target

Aug 30
Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Just Reported, And Analysts Assigned A HK$6.74 Price Target

Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 27% Share Price Plunge Could Signal Some Risk

Jun 25
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 27% Share Price Plunge Could Signal Some Risk

Here's What To Make Of Shandong Weigao Group Medical Polymer's (HKG:1066) Decelerating Rates Of Return

Jun 23
Here's What To Make Of Shandong Weigao Group Medical Polymer's (HKG:1066) Decelerating Rates Of Return

Shandong Weigao Group Medical Polymer's (HKG:1066) Shareholders Will Receive A Bigger Dividend Than Last Year

May 31
Shandong Weigao Group Medical Polymer's (HKG:1066) Shareholders Will Receive A Bigger Dividend Than Last Year

We Think Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) CEO Compensation Package Needs To Be Put Under A Microscope

May 22
We Think Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) CEO Compensation Package Needs To Be Put Under A Microscope

Earnings Not Telling The Story For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Apr 23
Earnings Not Telling The Story For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Analysts Have Lowered Expectations For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) After Its Latest Results

Mar 28
Analysts Have Lowered Expectations For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) After Its Latest Results

Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shares May Have Run Too Fast Too Soon

Jan 09
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shares May Have Run Too Fast Too Soon

Returns On Capital Are Showing Encouraging Signs At Shandong Weigao Group Medical Polymer (HKG:1066)

Dec 22
Returns On Capital Are Showing Encouraging Signs At Shandong Weigao Group Medical Polymer (HKG:1066)

Are Investors Undervaluing Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) By 44%?

Nov 10
Are Investors Undervaluing Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) By 44%?

Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Oct 05
Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Return Trends At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Appealing

Aug 01
Return Trends At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Appealing

Is Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Trading At A 28% Discount?

Jul 19
Is Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Trading At A 28% Discount?

Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

Jun 22
Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

Is Shandong Weigao Group Medical Polymer (HKG:1066) Using Too Much Debt?

Jun 09
Is Shandong Weigao Group Medical Polymer (HKG:1066) Using Too Much Debt?

The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Apr 27
The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

Mar 17
Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

A Look At The Intrinsic Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Feb 27
A Look At The Intrinsic Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Returns On Capital At Shandong Weigao Group Medical Polymer (HKG:1066) Have Hit The Brakes

Jan 18
Returns On Capital At Shandong Weigao Group Medical Polymer (HKG:1066) Have Hit The Brakes

Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Dec 12
Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 21% Below Their Intrinsic Value Estimate

Nov 29
Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 21% Below Their Intrinsic Value Estimate

Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today

Nov 14
Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today

Shandong Weigao Group Medical Polymer (HKG:1066) Is Paying Out A Larger Dividend Than Last Year

Oct 03
Shandong Weigao Group Medical Polymer (HKG:1066) Is Paying Out A Larger Dividend Than Last Year

The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Sep 21
The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Shandong Weigao Group Medical Polymer (HKG:1066) Could Easily Take On More Debt

Sep 05
Shandong Weigao Group Medical Polymer (HKG:1066) Could Easily Take On More Debt

Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Intrinsic Value Is Potentially 27% Above Its Share Price

Aug 23
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Intrinsic Value Is Potentially 27% Above Its Share Price

Here's Why Shandong Weigao Group Medical Polymer (HKG:1066) Has Caught The Eye Of Investors

Aug 08
Here's Why Shandong Weigao Group Medical Polymer (HKG:1066) Has Caught The Eye Of Investors

There's Been No Shortage Of Growth Recently For Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital

Jun 22
There's Been No Shortage Of Growth Recently For Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital

Shandong Weigao Group Medical Polymer (HKG:1066) Will Pay A Smaller Dividend Than Last Year

Jun 08
Shandong Weigao Group Medical Polymer (HKG:1066) Will Pay A Smaller Dividend Than Last Year

An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 27% Undervalued

May 16
An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 27% Undervalued

Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?

May 03
Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?

Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital Are Heading Higher

Mar 17
Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital Are Heading Higher

Is There An Opportunity With Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 42% Undervaluation?

Jan 28
Is There An Opportunity With Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 42% Undervaluation?

Does Shandong Weigao Group Medical Polymer (HKG:1066) Deserve A Spot On Your Watchlist?

Jan 13
Does Shandong Weigao Group Medical Polymer (HKG:1066) Deserve A Spot On Your Watchlist?

Returns Are Gaining Momentum At Shandong Weigao Group Medical Polymer (HKG:1066)

Dec 17
Returns Are Gaining Momentum At Shandong Weigao Group Medical Polymer (HKG:1066)

Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly

Dec 05
Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly

An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 32% Undervalued

Oct 18
An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 32% Undervalued

Do Shandong Weigao Group Medical Polymer's (HKG:1066) Earnings Warrant Your Attention?

Oct 06
Do Shandong Weigao Group Medical Polymer's (HKG:1066) Earnings Warrant Your Attention?

Aktionärsrenditen

1066HK Medical EquipmentHK Markt
7D-7.9%-4.6%-2.7%
1Y-42.2%-37.3%10.9%

Rendite im Vergleich zur Industrie: 1066 unter dem Niveau der Branche Hong Kong Medical Equipment , die im vergangenen Jahr eine Rendite von -37.3% erzielte.

Rendite vs. Markt: 1066 hinter dem Markt Hong Kong zurück, der im vergangenen Jahr eine Rendite von 10.9 erzielte.

Preisvolatilität

Is 1066's price volatile compared to industry and market?
1066 volatility
1066 Average Weekly Movement8.1%
Medical Equipment Industry Average Movement9.9%
Market Average Movement9.0%
10% most volatile stocks in HK Market19.0%
10% least volatile stocks in HK Market4.2%

Stabiler Aktienkurs: 1066 hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.

Volatilität im Zeitverlauf: 1066Die wöchentliche Volatilität (8%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

GegründetMitarbeiterCEOWebsite
200012,606Rinan Congwww.weigaogroup.com

Die Shandong Weigao Group Medical Polymer Company Limited ist in der Volksrepublik China in den Bereichen Forschung und Entwicklung, Produktion, Großhandel und Verkauf von medizinischen Geräten tätig. Das Unternehmen ist in den Segmenten Medizinische Produkte, Orthopädische Produkte, Interventionelle Produkte, Pharmazeutische Verpackungsprodukte, Blutmanagementprodukte und Sonstige tätig. Das Unternehmen bietet medizinische Verbrauchsmaterialien für den einmaligen Gebrauch an, darunter Infusionssets, Spritzen, Blutbeutel und Blutkomponententrenner, Produkte zur Blutentnahme, vorgefüllte Spritzen für vorverpackte Medikamente und medizinische Nadeln, die hauptsächlich intravenöse Nadeln, Spritzennadeln, Nadeln für intravenöse Katheter, Nadeln zur Blutentnahme und unregelmäßige Nadeln umfassen; orthopädische Materialien und Instrumente, darunter Traumaprodukte aus Stahlplatten und -schrauben, Wirbelsäulenimplantate und künstliche Gelenke; und Verbrauchsmaterialien und Geräte für die Blutreinigung, darunter Punktionsnadeln, extrakorporale Blutkreisläufe für Blutreinigungssets, Dialysatoren und zugehörige Verbrauchsmaterialien.

Shandong Weigao Group Medical Polymer Company Limited's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Shandong Weigao Group Medical Polymer im Vergleich zum Marktanteil des Unternehmens?
1066 grundlegende Statistiken
MarktanteilHK$20.75b
Gewinn(TTM)HK$2.06b
Umsatz(TTM)HK$13.96b

10.1x

Kurs-Gewinn-Verhältnis

1.5x

Kurs-Umsatz-Verhältnis

Ist 1066 zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
1066 Gewinn- und Verlustrechnung (TTM)
EinnahmenCN¥12.97b
Kosten der EinnahmenCN¥6.52b
BruttogewinnCN¥6.44b
Sonstige AusgabenCN¥4.53b
UmsatzCN¥1.91b

Zuletzt gemeldete Gewinne

Jun 30, 2024

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)0.42
Bruttomarge49.69%
Nettogewinnspanne14.74%
Schulden/Eigenkapital-Verhältnis16.3%

Wie hat sich 1066 auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

3.9%

Aktuelle Dividendenrendite

44%

Ausschüttungsquote

Zahlt 1066 eine zuverlässige Dividende?

Siehe 1066 Dividendenhistorie und Benchmarks
Bis wann müssen Sie 1066 kaufen, um eine kommende Dividende zu erhalten?
Shandong Weigao Group Medical Polymer Dividendentermine
Ex-Dividenden DatumOct 18 2024
Datum der DividendenzahlungNov 22 2024
Tage bis Ex-Dividende32 days
Tage bis zum Datum der Dividendenzahlung3 days

Zahlt 1066 eine zuverlässige Dividende?

Siehe 1066 Dividendenhistorie und Benchmarks